| 1. | | No longer recruiting | Biological Therapy Following Surgery and Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Lung Cancer
Conditions: extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer; limited stage small cell lung cancer; stage IV non-small cell lung cancer; ... |
| 2. | | No longer recruiting | Biological Therapy Following Surgery and Chemotherapy in Treating Patients With Stage III or Stage IV Breast Cancer
Conditions: stage IIIB breast cancer; stage IV breast cancer; stage IIIA breast cancer; recurrent breast cancer |
| 3. | | No longer recruiting | Biological Therapy Following Surgery and Chemotherapy in Treating Patients With Stage III or Stage IV Colon Cancer
Conditions: recurrent colon cancer; stage III colon cancer; stage IV colon cancer |
| 4. | | No longer recruiting | Biological Therapy Following Surgery and Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
Conditions: stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian germ cell tumor; recurrent ovarian epithelial cancer; ... |
| 5. | | Recruiting | Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
Condition: adult brain tumor |
| 6. | | No longer recruiting | Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Kidney Cancer
Conditions: stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer |
| 7. | | No longer recruiting | Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma
Conditions: Stage IV Melanoma; stage III melanoma; Recurrent Melanoma |
| 8. | | Recruiting | Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction
Conditions: adult non-Hodgkin's lymphoma; adult primary liver cancer; adult solid tumor |
| 9. | | Completed | Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer
Conditions: recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ... |
| 10. | | Completed | Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome
Conditions: Refractory Anemia; Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; refractory anemia with ringed sideroblasts; ... |
| 11. | | Completed | Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease
Condition: recurrent adult Hodgkin's disease |
| 12. | | Completed | Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma
Condition: refractory plasma cell neoplasm |
| 13. | | Completed | Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Conditions: recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ... |
| 14. | | Recruiting | Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
Conditions: stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; ... |
| 15. | | No longer recruiting | Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer
Condition: unspecified adult solid tumor, protocol specific |
| 16. | | Suspended | Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer
Conditions: stage IIIA non-small cell lung cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; ... |
| 17. | | Recruiting | Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer
Conditions: stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 18. | | No longer recruiting | Chemotherapy and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Condition: Leukemia |
| 19. | | No longer recruiting | Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer
Condition: Brain Tumor |
| 20. | | No longer recruiting | Chemotherapy in Treating Patients With Advanced Kidney Cancer
Conditions: stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer |
| 21. | | No longer recruiting | Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma
Conditions: recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ... |
| 22. | | No longer recruiting | Combination Chemotherapy In Treating Patients With Advanced Cancer
Condition: unspecified adult solid tumor, protocol specific |
| 23. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery
Conditions: recurrent pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer |
| 24. | | Completed | Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy
Conditions: stage IV prostate cancer; recurrent prostate cancer |
| 25. | | No longer recruiting | Fenretinide in Treating Patients With Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 26. | | Completed | Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 27. | | Recruiting | Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer
Condition: recurrent non-small cell lung cancer |
| 28. | | Recruiting | Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia
Conditions: blastic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ... |
| 29. | | Completed | KRN5500 in Treating Patients With Metastatic Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 30. | | Recruiting | Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 31. | | No longer recruiting | Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer
Conditions: stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer |
| 32. | | No longer recruiting | Pyrazoloacridine in Treating Women With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 33. | | Completed | Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer
Conditions: stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer |
| 34. | | Recruiting | Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate
Conditions: stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate |
| 35. | | No longer recruiting | XK469 in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 36. | | Recruiting | Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Lung Cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer |
